Pergolide in Parkinson's disease: time for a change?
Grosset
Katherine A
KA
Grosset
Donald G
DG
D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide / Q000009:adverse effects* / Q000627:therapeutic use
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D010479:Pergolide